Kovai Medical Center FY26 Results: Net profit rises 17% to ₹2,444.60 crore
Kovai Medical Center and Hospital Limited posted a 17% rise in net profit to ₹2,444.60 crore for FY26, fueled by a 15.65% increase in operating income to ₹1,58,563.68 lakh. Bed occupancy improved to 63.41%, and the education segment grew by 24.68%. The Board recommended a ₹15 dividend per share, reflecting strong cash flows and reduced leverage.

*this image is generated using AI for illustrative purposes only.
kovai medical center hospital reported a 17% year-on-year increase in net profit after tax (PAT) to ₹2,444.60 crore for the financial year ended March 31, 2026, driven by robust growth in patient volumes and higher average revenue per occupied bed. Operating income rose 15.65% to ₹1,58,563.68 lakh from ₹1,37,111.30 lakh in the previous year, while earnings before interest, tax, depreciation, and amortization (EBITDA) grew to ₹4,671.02 crore. The Board of Directors has recommended a final dividend of ₹15 per equity share, representing a 150% payout on the face value, subject to approval by shareholders at the 40th Annual General Meeting scheduled for August 26, 2026.
The company’s financial performance reflects sustained expansion across its healthcare and education segments. Inpatient revenues increased by 15.02% to ₹10,582.49 crore, supported by a rise in bed occupancy rates from 60.44% to 63.41%. Outpatient revenues grew by 14.94% to ₹4,105.12 crore. The education segment, operated through the KMCH Institute of Health Sciences and Research, contributed ₹1,153.91 crore, marking a 24.68% increase over the prior year. These gains were partially offset by higher employee benefit expenses, which rose to ₹3,064.85 crore, and increased costs for medicines and hospital consumables, which reached ₹4,480.79 crore.
Financial Highlights
| Metric | FY26 (₹ in Lakhs) | FY25 (₹ in Lakhs) | Change (%) |
|---|---|---|---|
| Operating Income | 1,58,563.68 | 1,37,111.30 | 15.65 |
| EBITDA | 4,671.02 | 4,078.17 | 14.54 |
| Profit Before Tax | 3,256.91 | 2,775.54 | 17.34 |
| Net Profit After Tax | 2,444.60 | 2,089.46 | 16.99 |
| Earnings Per Share | ₹223.41 | ₹190.95 | 16.99 |
Operational and Strategic Developments
During FY26, the hospital expanded its infrastructure with a capital expenditure of ₹1,184.51 crore on advanced medical technology. Key additions included Tamil Nadu’s first Varian ETHOS AI-powered Adaptive Radiation Therapy system and the Symbia Pro.Specta SPECT/CT scanner. The institution also inaugurated a new Institute of Neuro Sciences & OPD Block, representing a ₹120 crore investment. Clinically, the orthopedic team performed its 1,000th robotic-assisted knee replacement, and the critical care unit recorded 75 ECMO runs, the highest in the state. The Board approved the construction of a 300-bed Paediatric Hospital at the main center, with work expected to commence in the second quarter of 2026.
What the Numbers Show
The divergence between revenue growth and expense inflation highlights a margin compression risk despite top-line expansion. While operating income grew by 15.65%, employee benefit expenses surged by 22.02% to ₹3,064.85 crore, and consultant charges rose by 15.54% to ₹2,211.11 crore. This suggests that labor costs are outpacing revenue generation, potentially pressuring future profitability if occupancy rates do not continue to accelerate. Additionally, the net debt-to-equity ratio improved significantly to 4.39% from 13.27% in the previous year, indicating strengthened balance sheet resilience through internal cash flow generation rather than external leverage.
Corporate Governance and AGM Details
The 40th Annual General Meeting will be held via Video Conference/Other Audio Visual Means on August 26, 2026. Key agenda items include the adoption of audited financial statements for FY26, the declaration of dividends, and the reappointment of Dr. M.C. Thirumoorthi as a director liable to retire by rotation. The register of members will remain closed from August 20 to August 26, 2026. The record date for dividend entitlement is August 19, 2026. Statutory auditor M/s VKS Aiyer & Co issued an unmodified opinion on the financial statements, though they noted negative observations regarding non-registration of certain lease agreements and immovable property titles, which are currently sub judice or pending resolution.
Historical Stock Returns for Kovai Medical Center Hospital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.16% | -3.49% | -5.12% | +5.27% | +5.27% | +262.75% |
How will the upcoming construction of the 300-bed Paediatric Hospital impact Kovai Medical Center's capital expenditure trajectory and debt levels in FY27?
Given that employee benefit expenses grew at 22% while operating income rose only 15.65%, what specific operational efficiencies or pricing strategies can management deploy to prevent further margin compression?
What are the potential financial and legal repercussions of the statutory auditor's negative observations regarding non-registration of lease agreements and immovable property titles?


































